Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ortal Iancu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor CellsJenny Shapiro, Adi Tovin, Ortal Iancu, et al.
New Biotechnology|January 13, 2022
Microfluidic tool for rapid functional characterization of CRISPR complexesDana Peleg-Chen, Guy Shuvali, Lev Brio, et al.
The CRISPR Journal|January 20, 2022
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor CellsDaniel Allen, Lucien E Weiss, Alon Saguy, et al.
Nature Communications|October 27, 2023
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applicationsDaniel Allen, Orli Knop, Bryan Itkowitz, et al.
Molecular Therapy. Nucleic Acids|January 9, 2023
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCsOrtal Iancu, Daniel Allen, Orli Knop, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant SystemJenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Nature Communications|May 25, 2021
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS dataIdo Amit, Ortal Iancu, Alona Levy-Jurgenson, et al.
Cancer Research|August 24, 2016
WWOX and p53 Dysregulation Synergize to Drive the Development of OsteosarcomaSara Del Mare, Hussam Husanie, Ortal Iancu, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2020
Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor CellsJenny Shapiro, Adi Tovin, Ortal Iancu, et al.
New Biotechnology|January 13, 2022
Microfluidic tool for rapid functional characterization of CRISPR complexesDana Peleg-Chen, Guy Shuvali, Lev Brio, et al.
The CRISPR Journal|January 20, 2022
High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor CellsDaniel Allen, Lucien E Weiss, Alon Saguy, et al.
Nature Communications|October 27, 2023
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applicationsDaniel Allen, Orli Knop, Bryan Itkowitz, et al.
Molecular Therapy. Nucleic Acids|January 9, 2023
Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCsOrtal Iancu, Daniel Allen, Orli Knop, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant SystemJenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Nature Communications|May 25, 2021
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS dataIdo Amit, Ortal Iancu, Alona Levy-Jurgenson, et al.
Cancer Research|August 24, 2016
WWOX and p53 Dysregulation Synergize to Drive the Development of OsteosarcomaSara Del Mare, Hussam Husanie, Ortal Iancu, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Pageof 1